GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (FRA:GEM) » Definitions » Cash Receipts from Fees and Commissions

GeNeuro (FRA:GEM) Cash Receipts from Fees and Commissions


View and export this data going back to 2016. Start your Free Trial

What is GeNeuro Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applicable to companies reporting Cash Flow from Operations in direct method.


GeNeuro Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (FRA:GEM) » Definitions » Cash Receipts from Fees and Commissions
Traded in Other Exchanges
N/A
Address
3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).